Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022 Journal of Pharmaceutical Innovation Springer Nature Link The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York August 11, 2025: The FDA voices concern about sites that supply compounding ingredients Partnership for Safe Medicines FDA Sends 30 Warning Letters To Continue Clampdown on Compounded GLP 1s BioSpace The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B